Gut microbiota dysbiosis links chronic apical periodontitis to liver fibrosis in nonalcoholic fatty liver disease: Insights from a mouse model
- 3 July 2024
- journal article
- research article
- Published by Wiley in International Endodontic Journal
- Vol. 57 (11) , 1608-1622
Abstract
Aim: In this study, we investigated the systemic implications of chronic apical periodontitis (CAP). CAP may contribute to the nonalcoholic fatty liver disease (NAFLD) progression through the gut microbiota and its metabolites, which are related to the degree of fibrosis.Methodology: Sixteen 7‐week‐old male apolipoprotein E knockout (apoE−/−) mice were randomly divided into two groups: the CAP and Con groups. A CAP model was established by sealing the first‐ and second‐maxillary molars with bacterium‐containing cotton balls. Apical lesions were evaluated by micro‐CT. Histological evaluations of NAFLD were performed using second harmonic generation/two‐photon excitation fluorescence (SHG/TPEF) assays. Additionally, we comprehensively analyzed the gut microbiota using 16S rRNA gene sequencing and explored metabolic profiles by liquid chromatography–mass spectrometry (LC–MS). Immunofluorescence analysis was used to examine the impact of CAP on tight junction proteins and mucin expression. Transcriptome assays have elucidated gene expression alterations in liver tissues.Results: Micro‐CT scans revealed an evident periapical bone loss in the CAP group, and the total collagen percentage was increased (Con, 0.0361 ± 0.00510%, CAP, 0.0589 ± 0.00731%, p < .05). 16S rRNA sequencing revealed reduced diversity and distinct taxonomic enrichment in the CAP group. Metabolomic assessments revealed that differentially enriched metabolites, including D‐galactosamine, were enriched and that 16‐hydroxyhexadecanoic acid and 3‐methylindole were depleted in the CAP group. Immunofluorescence analyses revealed disruptions in tight junction proteins and mucin production, indicating intestinal barrier integrity disruption. Liver transcriptome analysis revealed upregulation of Lpin‐1 expression in the CAP group.Conclusion: This study provides comprehensive evidence of the systemic effects of CAP on liver fibrosis in NAFLD patients by elucidating alterations in the gut microbiota composition and metabolism.Keywords
Funding Information
- National Natural Science Foundation of China (81970926)
This publication has 47 references indexed in Scilit:
- Angiotensin converting enzyme inhibitors from medicinal plants: a molecular docking and dynamic simulation approachIn Silico Pharmacology, 2022
- Gut-liver axis: Pathophysiological concepts and clinical implicationsCell Metabolism, 2022
- Reliable computational quantification of liver fibrosis is compromised by inherent staining variationThe Journal of Pathology: Clinical Research, 2021
- Persistent changes in liver methylation and microbiome composition following reversal of diet-induced non-alcoholic-fatty liver diseaseCellular and Molecular Life Sciences, 2019
- Adipose‐Specific Lipin‐1 Overexpression Renders Hepatic Ferroptosis and Exacerbates Alcoholic Steatohepatitis in MiceHepatology Communications, 2019
- Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and DiseaseCell, 2017
- How lipid droplets “TAG” along: Glycerolipid synthetic enzymes and lipid storageBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2017
- Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver diseaseJournal of Gastroenterology, 2017
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host MetabolismCell Metabolism, 2016
- Preventive effects of 5-fluorouridine and uridine on d-galactosamine-induced liver injuryExperimental and Molecular Pathology, 1981